137 results
Page 5 of 7
20-F/A
EX-12.1
fx9vv0 1ggq
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
u88bn2
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
rw4e6ph
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
ejrrjrdq0n y7r
6 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
vivcc0fi
5 Mar 15
Current report (foreign)
12:00am
424B5
9q89v vqdfyac4y3t
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
w5xspg2tayb5k0o
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.3
wi0 romiif
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
v79s3n
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
hiu3q
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
424B2
zbhpkgvyppwdwotkpdpf
13 Jun 14
Prospectus for primary offering
12:00am
F-3
kuuobfdu
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
1w8fqr
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-1.1
qqq4 z6e0ueaudgxr
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am